LILLY ENDOWMENT INC - 24 Mar 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
10%+ Owner
Signature
/s/Peter A. Buck, Vice President for Investments & Grants Administration, on behalf of Lilly Endowment Inc.
Issuer symbol
LLY
Transactions as of
24 Mar 2023
Net transactions value
-$67,164,555
Form type
4
Filing time
27 Mar 2023, 10:31:58 UTC
Previous filing
05 Dec 2022
Next filing
03 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Sale $61,097,532 -181,976 -0.18% $335.74 102,766,834 24 Mar 2023 Direct F1
transaction LLY Common Stock Sale $6,067,023 -18,024 -0.02% $336.61 102,748,810 24 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.50 to $336.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.50 to $336.79, inclusive.